1. Home
  2. ENVB vs UK Comparison

ENVB vs UK Comparison

Compare ENVB & UK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENVB
  • UK
  • Stock Information
  • Founded
  • ENVB 1994
  • UK 2015
  • Country
  • ENVB United States
  • UK China
  • Employees
  • ENVB N/A
  • UK N/A
  • Industry
  • ENVB Biotechnology: Pharmaceutical Preparations
  • UK Business Services
  • Sector
  • ENVB Health Care
  • UK Consumer Discretionary
  • Exchange
  • ENVB Nasdaq
  • UK Nasdaq
  • Market Cap
  • ENVB 2.7M
  • UK 2.2M
  • IPO Year
  • ENVB N/A
  • UK N/A
  • Fundamental
  • Price
  • ENVB $1.19
  • UK $1.01
  • Analyst Decision
  • ENVB Strong Buy
  • UK
  • Analyst Count
  • ENVB 1
  • UK 0
  • Target Price
  • ENVB $10.00
  • UK N/A
  • AVG Volume (30 Days)
  • ENVB 81.9K
  • UK 11.4K
  • Earning Date
  • ENVB 08-14-2025
  • UK 09-26-2025
  • Dividend Yield
  • ENVB N/A
  • UK N/A
  • EPS Growth
  • ENVB N/A
  • UK N/A
  • EPS
  • ENVB N/A
  • UK N/A
  • Revenue
  • ENVB N/A
  • UK $23,924,045.00
  • Revenue This Year
  • ENVB N/A
  • UK N/A
  • Revenue Next Year
  • ENVB N/A
  • UK N/A
  • P/E Ratio
  • ENVB N/A
  • UK N/A
  • Revenue Growth
  • ENVB N/A
  • UK N/A
  • 52 Week Low
  • ENVB $1.01
  • UK $0.97
  • 52 Week High
  • ENVB $8.69
  • UK $1.83
  • Technical
  • Relative Strength Index (RSI)
  • ENVB 50.71
  • UK 47.99
  • Support Level
  • ENVB $1.10
  • UK $0.98
  • Resistance Level
  • ENVB $1.20
  • UK $1.00
  • Average True Range (ATR)
  • ENVB 0.07
  • UK 0.03
  • MACD
  • ENVB 0.01
  • UK -0.00
  • Stochastic Oscillator
  • ENVB 82.35
  • UK 62.86

About ENVB Enveric Biosciences Inc.

Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company's program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. The company is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, which is being studied as a treatment for psychiatric disorders.

About UK Ucommune International Ltd

Ucommune International Ltd is a flexible office space provider and manager based in the People's Republic of China (PRC). The company offers long-term leasing, on-demand, and short-term leasing solutions to freelancers, start-up entrepreneurs, small and medium enterprises, and corporations. Company provide fully-serviced and well-furnished office spaces on a flexible basis. The members of the Ucommune community, which includes individuals and enterprises registered on the U bazaar mobile app, can avail of these services. The company has three operating segments: Workspace membership, Marketing and branding services, and Other services. Marketing and branding services generate the majority of the company's revenue.

Share on Social Networks: